Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1428 of 6351
-
New device aims to make clot removal safer for lung patients
Disease control Recruiting nowThe investigation is intended to evaluate the safety and effectiveness of the AlphaReturn Blood Management System when used in conjunction with the cleared AlphaVac MMA F1885 System for the treatment of acute pulmonary embolism.
Sponsor: Angiodynamics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Engineered immune cells take on liver cancer in early trial
Disease control Not yet recruitingA Study of Metabolically Armed GPC3 CAR-T Cells Injection (Meta10-GPC3) in Patients with Unresectable Recurrent/Metastatic Hepatocellular Carcinoma.
Early phase 1 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New gel could boost recovery after sinus surgery
Disease control Not yet recruitingEndoscopic sinus surgery (ESS) is commonly performed in patients with chronic rhinosinusitis (CRS) to improve sinus drainage and allow better delivery of topical therapies after surgery. Despite surgery, postoperative inflammation can persist and negatively affect healing and out…
Phase 3 • Sponsor: Amin Javer • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New camera system spots hidden signs of awareness in brain injury patients
Knowledge-focused Recruiting nowObjective: This prospective interventional study introduces "SeeMe," an automated, high-resolution computer vision platform designed to objectively quantify microscopic, auditory command-evoked movements in patients with Traumatic Brain Injury (TBI). Current clinical assessments,…
Sponsor: Stony Brook University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New program aims to shield young female soccer stars from devastating knee injuries
Prevention Not yet recruitingAnterior cruciate ligament (ACL) injuries are common in female soccer and frequently occur during change-of-direction (COD) movements without contact. Biomechanical deficits during these movements are considered important risk factors. This study aims to evaluate the effects of …
Sponsor: University of Liege • Aim: Prevention
Last updated Jun 27, 2026 12:08 UTC
-
New drug zanzalintinib tested for advanced liver cancer
Disease control Recruiting nowThis phase Ib/II trial tests the safety, side effects, and best dose of zanzalintinib and how well it works in treating patients with hepatocellular (liver) cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanc…
Phase 1/2 • Sponsor: Devalingam Mahalingam • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Nurses take on PTSD: a new way to get help faster
Symptom relief Recruiting nowPurpose of the Study Post-traumatic stress disorder (PTSD) is a common and serious condition, but many people cannot get the help they need because there are not enough mental health specialists (like psychologists or psychiatrists) available. This study is testing a new program …
Sponsor: Rush University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Texting to beat HIV: simple phone messages could help women stay healthy
Disease control Recruiting nowThe goal of this clinical trial is to learn if an interactive mHealth intervention will be effective in helping HIV-positive women in high-burden settings who are initiating antiretroviral therapy (ART) take their ART regularly as prescribed, effectively reducing their viral load…
Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Could steroids save your joints after a severe infection?
Disease control Not yet recruitingSeptic arthritis is a severe infection associated with significant morbidity and mortality. Despite eradication of the microorganisms, persistent inflammation may lead to substantial long-term functional joint sequelae. The use of corticosteroids could reduce this inflammation, t…
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Ear seeds vs. eye drops: new study aims to stop myopia before it starts
Prevention Not yet recruitingThis project aims to address the trend of early onset and high myopia among children in China by focusing on insufficient hyperopia reserve, a key early warning indicator for myopia. A randomized controlled trial (RCT) will be conducted. The study will target children aged 4 to 1…
Sponsor: Fangbiao Tao • Aim: Prevention
Last updated Jun 27, 2026 11:02 UTC
-
Can a smartphone app beat anxiety? new trial combines digital therapy with drugs
Symptom relief Recruiting nowTo evaluate the superiority of cognitive behavioral therapy using the Aurora® digital medical device + conventional drug treatment, compared to conventional drug treatment alone, in reducing anxiety symptoms, as assessed by the change in the GAD-7 scale at 12 weeks of treatment, …
Phase 3 • Sponsor: Psicofarma, S.A. De C.V. • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
New drug aims to calm kidney attack by antibodies
Disease control Recruiting nowThe purpose of this study is to assess the safety, tolerability, pharmacokinetic, and efficacy of surovatamig administered by subcutaneous injection in adult participants with primary membranous nephropathy.
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New hope for ulcerative colitis sufferers: drug trial launches
Disease control Recruiting nowThis study will evaluate the efficacy and safety of 627 in patients with UC.
Phase 2 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Wearable tech as a stress buster for future nurses?
Symptom relief OngoingThis randomized controlled trial aims to evaluate the effectiveness of smart watch monitoring in reducing stress levels among nursing students during older adult clinical training. Nursing students often experience psychological stress during geriatric clinical practice due to co…
Sponsor: doaa mansour ali • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
Could a Mother's thyroid or anxiety affect her Baby's heart tracing?
Knowledge-focused Recruiting nowThis prospective observational study aims to investigate the association between maternal thyroid function, maternal anxiety levels, and fetal cardiotocography parameters in high-risk pregnancies. Pregnant women at 32 weeks of gestation or later who are followed in the perinatolo…
Sponsor: Istanbul Training and Research Hospital • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
New drug cocktail aims to boost bile duct cancer treatment
Disease control Recruiting nowBased on preclinical data from the Lim lab (WUSM), the investigators hypothesize that IRAK4 inhibition cripples tumor-intrinsic survival signaling and effectively overcomes the desmoplastic and immune-suppressive tumor microenvironment (TME) to render chemo- and immunotherapies e…
Phase 1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New diabetes drug HDM1005 takes on mazdutide in major trial
Disease control Not yet recruitingThis study is a multicenter, randomized, open-label, parallel-group, phase 3 clinical trial aimed at evaluating the efficacy and safety of HDM1005 versus active comparator in subjects with Type 2 Diabetes Mellitus (T2DM) Inadequate Glycemic Control by Metformin Monotherapy or in …
Phase 3 • Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New cocktail therapy targets rare cancer after standard treatment fails
Disease control Recruiting nowThis is a single-arm, multicenter phase Ⅱ study to evaluate the therapeutic efficacy and safety of chidamide + sintilimab + bevacizumab in subjects with advanced extrapulmonary neuroendocrine carcinoma who have failed first-line standard therapy. The primary purpose is to assess …
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New drug combo targets tough cancers in early trial
Disease control Recruiting nowAn open-label, multi-site, multi-cohort phase 1/2 trial to be conducted in 2 parts (dose escalation and dose expansion/optimisation)
Phase 1/2 • Sponsor: Orion Corporation, Orion Pharma • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Blood product showdown: which stops bleeding faster in heart surgery?
Disease control Recruiting nowThe primary endpoint of this study is the completion time of hemostasis treatment when administered Fresh frozen plasma (FFP) and frozen powder coagulation factor concentrate (PCC) in goal-directed bleeding management for cardiac surgery.
Phase 4 • Sponsor: Konkuk University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC